PLAN-e-PSY, a mobile application to improve case management and patient's functioning in first episode psychosis: protocol for an open-label, multicentre, superiority, randomised controlled trial

Frédéric Haesebaert, Sofia El Oussoul, Amélie Pavard, Delphine Fabre, Caroline Cellard, Laurent Magaud, Fabien Subtil, Eleonore Damiolini, Eric Fakra, Julie Haesebaert, Frédéric Haesebaert, Sofia El Oussoul, Amélie Pavard, Delphine Fabre, Caroline Cellard, Laurent Magaud, Fabien Subtil, Eleonore Damiolini, Eric Fakra, Julie Haesebaert

Abstract

Introduction: The prognosis of first episode psychosis (FEP), which is a severe disorder, can be notably impaired by patients' disengagement from healthcare providers. Coordinated specialty care with case management is now considered as the gold standard in this population, but there are still challenges for engagement with subsequent functional impairments. Youth-friendly and patient-centred clinical approaches are sought to improve engagement in patients with FEP. Mobile applications are widely used by young people, including patients with FEP, and can increase the youth friendliness of clinical tools. We hypothesise that a co-designed mobile application used during case management can improve functioning in patients with FEP as compared with usual case management practices.

Methods and analysis: A mobile case management application for planning and monitoring individualised care objectives will be co-designed with patients, caregivers and health professionals in a recovery-oriented approach. The application will be compared with usual case management practices in a multicentre, two-arm and parallel groups clinical trial. Patients will be recruited by specialised FEP teams. Impact on functioning will be assessed using the Personal and Social Performance Scale; the variation between baseline and 12 months in each group (control and active) will be the primary outcome.

Ethics and dissemination: This study has been approved by the Inserm Institutional Review Board IRB00003888 (Comité d'évaluation éthique de l'INSERM, reference number 20-647). The results of the study will be published in a peer-reviewed journal and presented at national and international conferences. We will also communicate the results to patients and family representatives' associations. An optimised version of the application will be then disseminated through the French FEP network (Transition Network).

Trial registration number: ClinicalTrials.gov: NCT04657380.

Keywords: adult psychiatry; psychiatry; schizophrenia & psychotic disorders.

Conflict of interest statement

Competing interests: FH reports receipt of personal fees or non-financial support not directly related to this study from Janssen, Lundbeck and Otsuka. EF reports receipt of personal fees or non-financial support not directly related to this study from Janssen, Lundbeck, Otsuka, Recordatti, Sanofi, AbbVie, MSD. JH reports receipt of personal fees or non-financial support not directly related to this study from Janssen. SEO, AP, DF, CC, LM, ED and FS report no financial relationships with commercial interests.

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Design diagram of the PLAN-e-PSY application.
Figure 2
Figure 2
Example of a possible prototype for PLAN-e-PSY.

References

    1. Kirkbride JB, Hameed Y, Ankireddypalli G, et al. . The Epidemiology of First-Episode Psychosis in Early Intervention in Psychosis Services: Findings From the Social Epidemiology of Psychoses in East Anglia [SEPEA] Study. Am J Psychiatry 2017;174:143–53. 10.1176/appi.ajp.2016.16010103
    1. Perälä J, Suvisaari J, Saarni SI, et al. . Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry 2007;64:19–28. 10.1001/archpsyc.64.1.19
    1. Pompili M, Serafini G, Innamorati M, et al. . Suicide risk in first episode psychosis: a selective review of the current literature. Schizophr Res 2011;129:1–11. 10.1016/j.schres.2011.03.008
    1. Birchwood M, Todd P, Jackson C. Early intervention in psychosis. The critical period hypothesis. Br J Psychiatry 1998;172:53–9.
    1. Penttilä M, Jääskeläinen E, Hirvonen N, et al. . Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis. Br J Psychiatry 2014;205:88–94. 10.1192/bjp.bp.113.127753
    1. Nordentoft M, Madsen T, Fedyszyn I. Suicidal behavior and mortality in first-episode psychosis. J Nerv Ment Dis 2015;203:387–92. 10.1097/NMD.0000000000000296
    1. Shiers D, Jones PB, Field S. Early intervention in psychosis: keeping the body in mind. Br J Gen Pract 2009;59:395. 10.3399/bjgp09X420888
    1. Berk LE. Emotional and social development in early adulthood. In: Development through the lifespan, 2018.
    1. McGorry PD. Early intervention in psychosis: obvious, effective, overdue. J Nerv Ment Dis 2015;203:310–8. 10.1097/NMD.0000000000000284
    1. Correll CU, Galling B, Pawar A, et al. . Comparison of early intervention services vs treatment as usual for early-phase psychosis: a systematic review, meta-analysis, and meta-regression. JAMA Psychiatry 2018;75:555–65. 10.1001/jamapsychiatry.2018.0623
    1. McGorry PD, Jackson HJ. The recognition and management of early psychosis : a preventive approach. Cambridge; New York: Cambridge University Press, 1999.
    1. Holloway F, Oliver N, Collins E, et al. . Case management: a critical review of the outcome literature. Eur Psychiatry 1995;10:113–28. 10.1016/0767-399X(96)80101-5
    1. Early Psychosis Guidelines Writing Group and EPPIC National Support Program . Australian clinical guidelines for early psychosis. 2nd edn. Orygen, Melbourne: The National Centre of Excellence in Youth Mental Health, 2016.
    1. Lal S, Malla A. Service engagement in First-Episode psychosis: current issues and future directions. Can J Psychiatry 2015;60:341–5. 10.1177/070674371506000802
    1. Alvarez-Jimenez M, Priede A, Hetrick SE, et al. . Risk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studies. Schizophr Res 2012;139:116–28. 10.1016/j.schres.2012.05.007
    1. Di Capite S, Upthegrove R, Mallikarjun P. The relapse rate and predictors of relapse in patients with first-episode psychosis following discontinuation of antipsychotic medication. Early Interv Psychiatry 2018;12:893–9. 10.1111/eip.12385
    1. Dixon LB, Holoshitz Y, Nossel I. Treatment engagement of individuals experiencing mental illness: review and update. World Psychiatry 2016;15:13–20. 10.1002/wps.20306
    1. Smith TE, Easter A, Pollock M, et al. . Disengagement from care: perspectives of individuals with serious mental illness and of service providers. Psychiatr Serv 2013;64:770–5. 10.1176/appi.ps.201200394
    1. Mcdaid D, Park A-L, Iemmi V, et al. . Growth in the use of early intervention for psychosis services: an opportunity to promote recovery amid concerns on health care sustainability, 2016.
    1. Schürhoff F, Fond G, Berna F, et al. . A national network of schizophrenia expert centres: an innovative tool to bridge the research-practice gap. Eur Psychiatry 2015;30:728–35. 10.1016/j.eurpsy.2015.05.004
    1. Courouve L, Duburcq A, Gozlan G, et al. . Mapping of early intervention programs for psychosis in France in 2018. Eur J Public Health 2019;29. 10.1093/eurpub/ckz186.559
    1. Lal S, Malla A. Service engagement in first-episode psychosis: current issues and future directions. Can J Psychiatry 2015;60:341–5. 10.1177/070674371506000802
    1. Torous J, Woodyatt J, Keshavan M, et al. . A new hope for early psychosis care: the evolving landscape of digital care tools. Br J Psychiatry 2019;214:269–72. 10.1192/bjp.2019.8
    1. Firth J, Cotter J, Torous J, et al. . And endorsement of « mHealth » among people with psychosis: a meta-analysis of cross-sectional studies. Schizophr Bull. mars 2016;42:448–55.
    1. Niendam TA, Tully LM, Iosif A-M, et al. . Enhancing early psychosis treatment using smartphone technology: a longitudinal feasibility and validity study. J Psychiatr Res 2018;96:239–46. 10.1016/j.jpsychires.2017.10.017
    1. Hardy A, Wojdecka A, West J, et al. . How inclusive, User-Centered design research can improve psychological therapies for psychosis: development of SlowMo. JMIR Ment Health 2018;5:e11222. 10.2196/11222
    1. Ramsay CE, Broussard B, Goulding SM, et al. . Life and treatment goals of individuals hospitalized for first-episode nonaffective psychosis. Psychiatry Res 2011;189:344–8. 10.1016/j.psychres.2011.05.039
    1. Whitley R, Drake RE. Recovery: a dimensional approach. Psychiatr Serv 2010;61:1248–50. 10.1176/ps.2010.61.12.1248
    1. Pomini V, Bonsack C. Chapitre 6 - Modèles théoriques du rétablissement. In: Franck N, ed. Traité de Réhabilitation Psychosociale [online. Paris: Elsevier Masson, 2018: 55–63.
    1. Zhou L, DeAlmeida D, Parmanto B. Applying a user-centered approach to building a mobile personal health record APP: development and usability study. JMIR Mhealth Uhealth 2019;7:e13194. 10.2196/13194
    1. Torous J, Wisniewski H, Liu G, et al. . Mental health mobile phone APP usage, concerns, and benefits among psychiatric outpatients: comparative survey study. JMIR Ment Health 2018;5:e11715. 10.2196/11715
    1. McGorry PD, Edwards J, Mihalopoulos C, et al. . EPPIC: an evolving system of early detection and optimal management. Schizophr Bull 1996;22:305–26. 10.1093/schbul/22.2.305
    1. Morosini PL, Magliano L, Brambilla L, et al. . Development, reliability and acceptability of a new version of the DSM-IV social and occupational functioning assessment scale (SOFAS) to assess routine social functioning. Acta Psychiatr Scand 2000;101:323–9.
    1. Tait L, Birchwood M, Trower P. A new scale (Ses) to measure engagement with community mental health services. J Ment Health 2002;11:191–8. 10.1080/09638230020023570-2
    1. Horvath AO, Greenberg LS. Development and validation of the working alliance inventory. J Couns Psychol 1989;36:223–33. 10.1037/0022-0167.36.2.223
    1. Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new medication adherence rating scale (MARS) for the psychoses. Schizophr Res 2000;42:241–7. 10.1016/s0920-9964(99)00130-9
    1. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261–76. 10.1093/schbul/13.2.261
    1. Andresen R, Caputi P, Oades L. Stages of recovery instrument: development of a measure of recovery from serious mental illness. Aust N Z J Psychiatry 2006;40:972–80. 10.1080/j.1440-1614.2006.01921.x
    1. Boyer L, Simeoni M-C, Loundou A, et al. . The development of the S-QoL 18: a shortened quality of life questionnaire for patients with schizophrenia. Schizophr Res 2010;121:241–50. 10.1016/j.schres.2010.05.019
    1. Chang WC, Kwong VWY, Lau ESK, et al. . Sustainability of treatment effect of a 3-year early intervention programme for first-episode psychosis. Br J Psychiatry 2017;211:37–44. 10.1192/bjp.bp.117.198929
    1. Fleiss JL, Tytun A, Ury HK. A simple approximation for calculating sample sizes for comparing independent proportions. Biometrics 1980;36:343–6. 10.2307/2529990
    1. R Foundation for Statistical Computing . Core team R. R: a language and environment for statistical computing. Vienna, 2020.
    1. Nevarez-Flores AG, Sanderson K, Breslin M, et al. . Systematic review of global functioning and quality of life in people with psychotic disorders. Epidemiol Psychiatr Sci 2019;28:31–44. 10.1017/S2045796018000549
    1. Blanc O, Delgado A, Lancon C, et al. . Psychometric properties of the French version of the personal and social performance scale (PSP) among individuals with schizophrenia. Schizophrenia Research 2010;117:285–6.
    1. Martinuzzi E, Barbosa S, Daoudlarian D. Bel Haj Ali W, Gilet C, Fillatre L, et al. stratification and prediction of remission in first-episode psychosis patients: the optimise cohort study. Transl Psychiatry 2019;9:20.
    1. Albert N, Melau M, Jensen H, et al. . Five years of specialised early intervention versus two years of specialised early intervention followed by three years of standard treatment for patients with a first episode psychosis: randomised, superiority, parallel group trial in Denmark (OPUS II). BMJ. 12 janv 2017;356:i6681.
    1. Alvarez-Jimenez M, Koval P, Schmaal L, et al. . The Horyzons project: a randomized controlled trial of a novel online social therapy to maintain treatment effects from specialist first-episode psychosis services. World Psychiatry 2021;20:233–43. 10.1002/wps.20858
    1. Faay MDM, van Baal GCM, Arango C, et al. . Hostility and aggressive behaviour in first episode psychosis: results from the optimise trial. Schizophr Res 2020;223:271–8. 10.1016/j.schres.2020.08.021

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する